Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA)

Miller, P.D.E., Patel, S.R., Skinner, R. orcid.org/0000-0002-1162-675X et al. (9 more authors) (2023) Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA). Journal of Infection, 86 (1). pp. 1-8. ISSN 0163-4453

Abstract

Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered ‘never vaccinated’ and offered a comprehensive course of revaccination. This position statement aims to draw upon the current evidence base and existing guidelines, and align this with national vaccine availability and licensing considerations in order to recommend a pragmatic and standardised re-vaccination schedule for adult and paediatric HSCT recipients in the UK.

Metadata

Item Type:	Article
Authors/Creators:	Miller, P.D.E. Patel, S.R. Skinner, R. https://orcid.org/0000-0002-1162-675X Dignan, F. Richter, A. Jeffery, K. https://orcid.org/0000-0002-6506-2689 Khan, A. https://orcid.org/0000-0001-6432-6999 Heath, P.T. Clark, A. Orchard, K. https://orcid.org/0000-0003-2276-3925 Snowden, J.A. https://orcid.org/0000-0001-6819-3476 de Silva, T.I. https://orcid.org/0000-0002-6498-9212
Copyright, Publisher and Additional Information:	© 2022 The Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords:	Haematopoietic stem cell transplant; Immunisation; Vaccination; Adult; Child; Humans; Bone Marrow; Hematopoietic Stem Cell Transplantation; Leukemia; Transplant Recipients; Vaccination; Vaccines
Dates:	Published: January 2023 Published (online): 15 November 2022 Accepted: 10 November 2022
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield) The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease
Depositing User:	Symplectic Sheffield
Date Deposited:	06 Mar 2023 15:49
Last Modified:	06 Mar 2023 15:49
Published Version:	http://dx.doi.org/10.1016/j.jinf.2022.11.005
Status:	Published
Publisher:	Elsevier BV
Refereed:	Yes
Identification Number:	10.1016/j.jinf.2022.11.005
Related URLs:	PubMed URL
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:197019

Download

Published Version

Filename: Miller et al, JoI 2023.pdf

Licence: CC-BY 4.0

CLICK TO DOWNLOAD

[thumbnail of Miller et al, JoI 2023.pdf]

CORE (COnnecting REpositories)

Abstract

Metadata

Download

Published Version

Export

Statistics